Location History:
- Tuusula, FI (2016 - 2019)
- Turku, FI (2019)
- Kaarina, FI (2020 - 2022)
Company Filing History:
Years Active: 2016-2022
Title: Tero Linnanen: Innovator in Therapeutically Active Steroidal Derivatives
Introduction
Tero Linnanen is a notable inventor based in Tuusula, Finland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutically active steroidal derivatives. With a total of six patents to his name, Linnanen's work focuses on innovative compounds that have the potential to treat various steroid hormone-dependent diseases.
Latest Patents
Linnanen's latest patents include inventions related to compounds of formula (II) and (I), which are pharmaceutically acceptable salts. These compounds serve as inhibitors of the 17β-HSD1 enzyme, which is crucial in the treatment or prevention of steroid hormone-dependent diseases. His inventions aim to lower endogenous estradiol concentrations, thereby addressing disorders that require such intervention. The patents also detail the preparation of these compounds and the pharmaceutical compositions that incorporate them as active ingredients.
Career Highlights
Throughout his career, Tero Linnanen has worked with prominent companies in the pharmaceutical industry, including Orion Corporation and Forendo Pharma Ltd. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.
Collaborations
Linnanen has collaborated with several professionals in his field, including Ravi Kotrabasaiah Ujjinamatada and Subhendu Mukherjee. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Tero Linnanen's contributions to the field of therapeutically active steroidal derivatives highlight his innovative spirit and dedication to improving healthcare. His patents represent significant advancements in the treatment of steroid hormone-dependent diseases, showcasing the impact of his work in the pharmaceutical industry.